The 37th Day in Primary Eye Care for Family Physicians
Transcription
The 37th Day in Primary Eye Care for Family Physicians
The 37th Day in Primary Eye Care for Family Physicians Saturday, December 13, 2014 0700 - 0745 Registration and Continental Breakfast 0745 - 0800 Welcome - Dr. L. Weisbrod (Chairman) Session 1 Moderator – Dr. Lawrence Weisbrod 0800 - 0830 Basic Anatomy, Physiology and Examination of the Eye Dr. John Lloyd 0830 - 0845 TBD 0845 - 0900 An Approach to Diplopia Dr. Arun Sundaram 0900 - 0915 Pediatric Emergencies in the First 6 Months of Life Dr. Robert Adam 0915 - 0930 An Update on Amblyopia and Strabismus Dr. Michael Richards 0930 - 0945 An Update on Glaucoma – Diagnostics Dr. Catherine Birt 0945 - 1000 Question & Answer Period (Panel) 1000 - 1015 Refreshments & Exhibits Session 2 Moderator - TBD 1015 – 1030 An Update on Glaucoma – Therapeutics Dr. Catherine Birt 1030 - 1045 An Update on Age-Related Macular Degeneration Dr. Daniel Weisbrod 1045 – 1100 Floaters and Flashes: What the Family Physician Needs to Know Dr. Efrem Mandelcorn 1100 - 1115 Traumatic Eye Disease – Part 1 Dr. Kylen McRealis 1115 - 1130 Traumatic Eye Disease – Part 2 Dr. Kylen McRealis 1130 - 1145 Mystery Slide Quiz - Part 1 Dr. John Fowler 1145 - 1200 Question & Answer Period (Panel) 1200 - 1300 Luncheon Session 3 Moderator – Dr. John Fowler 1300 - 1315 Mystery Slide Quiz - Part 2 Dr. John Fowler 1315 – 1330 New Advances in Cataract Surgery Dr. Moss Weinstock 1330 – 1345 Corneal Manifestations of Systemic Disease Dr. Hall Chew 1345 - 1400 Involutional Changes to the Eyes and Face Dr. Harmeet Gill 1400 - 1415 An Update on Refractive Eye Surgery TBD 1415 – 1430 Question & Answer Period (Panel) 1430 - 1445 Refreshments & Exhibits Session 4 Moderator – TBD 1445 - 1500 Pupils and The Swinging Flashlight Test Dr. Lawrence Weisbrod 1500 – 1515 Acute Painless Visual Loss Dr. Ted Christakis 1515 - 1530 Cosmetics and the Eye Speaker TBD 1530 – 1545 The Red Eye – Identifying Vision Threatening Causes Dr. Lawrence Weisbrod 1545 – 1600 Question & Answer Period (Panel) 1600 Closing Remarks – Dr. Lawrence Weisbrod